Nivolumab (nabumab) is a fully humanized IgG4 monoclonal antibody against PD-1. It has immune checkpoint inhibitory activity and antitumor activity, MW: 143.597 KD.(for human-derived mice).
Purity:
>99.0%
CAS Number:
[946414-94-4]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
